Takeharu Shiroki
Overview
Explore the profile of Takeharu Shiroki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oikawa T, Ikehata A, Nakayama M, Shiroki T
Intern Med
. 2025 Feb;
PMID: 39894495
No abstract available.
2.
Tanaka I, Hatta W, Koike T, Takahashi S, Shimada T, Hikichi T, et al.
Dis Esophagus
. 2024 Jun;
37(11).
PMID: 38869095
Although esophageal cancers invading the muscularis mucosa (pT1a-MM) or submucosa (pT1b-SM) after endoscopic resection (ER) are associated with a risk of lymph node metastasis, details of metastatic recurrence after additional...
3.
Toya Y, Hatta W, Shimada T, Matsuhashi T, Shiroki T, Sasaki Y, et al.
Dig Endosc
. 2023 Jun;
36(3):314-322.
PMID: 37343173
Objectives: Clinical outcomes of endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) with esophageal varices (EVs) are obscure. We aimed to elucidate the clinical outcomes of ESD for...
4.
Hatta W, Toya Y, Shimada T, Hamada K, Watanabe K, Nakamura J, et al.
J Gastroenterol
. 2023 Jan;
58(4):346-357.
PMID: 36633664
Background: The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We...
5.
Takahashi S, Hatta W, Watanabe K, Koike T, Shimada T, Hikichi T, et al.
Dig Dis Sci
. 2022 Nov;
68(5):2050-2060.
PMID: 36445654
Background: Although additional treatment is considered for patients with esophageal squamous cell carcinoma (ESCC) invading into the muscularis mucosa (pT1a-MM) or submucosa (pT1b-SM) after endoscopic submucosal dissection (ESD), the actual...
6.
Shimada T, Hatta W, Takahashi S, Koike T, Ohira T, Hikichi T, et al.
Dig Endosc
. 2022 Jun;
34(7):1382-1391.
PMID: 35702926
Objectives: We aimed to clarify the prognostic factors for patients with esophageal squamous cell carcinoma (ESCC) invading into the muscularis mucosa (pT1a-MM) or submucosa (pT1b-SM) after endoscopic submucosal dissection (ESD)....
7.
Toya Y, Shimada T, Hamada K, Watanabe K, Nakamura J, Fukushi D, et al.
J Cancer Res Clin Oncol
. 2022 May;
149(4):1521-1530.
PMID: 35546359
Purpose: Little is known about the prognostic factors for survival after endoscopic submucosal dissection (ESD) in elderly patients with early gastric cancer (EGC). The aim of this study is to...
8.
Hatta W, Koike T, Takahashi S, Shimada T, Hikichi T, Toya Y, et al.
J Gastroenterol
. 2021 Apr;
56(7):620-632.
PMID: 33881632
Background: We aimed to elucidate the risk of metastatic recurrence after endoscopic resection (ER) without additional treatment for esophageal squamous cell carcinomas (ESCCs) with tumor invasion into the muscularis mucosa...
9.
Yokoyama M, Tanuma N, Shibuya R, Shiroki T, Abue M, Yamamoto K, et al.
Int J Oncol
. 2018 Feb;
52(3):881-891.
PMID: 29393401
The majority of cancer cells maintain a high glycolytic activity and an increased lactate production, even in a well oxygenated environment. This phenomenon is known as the Warburg effect. Previous...
10.
Shiroki T, Yokoyama M, Tanuma N, Maejima R, Tamai K, Yamaguchi K, et al.
Cancer Sci
. 2017 Feb;
108(5):931-940.
PMID: 28235245
Recent studies have indicated that increased expression of the M2 isoform of pyruvate kinase (PKM2) is involved in glycolysis and tumor development. However, little is known about the role of...